Stem cells restore hearing, vision in animals

By Maggie Fox, Health and Science Editor

WASHINGTON (Reuters) - Stem cells from tiny embryos can be used to restore lost hearing and vision in animals, researchers said Tuesday in what they believe is a first step toward helping people.

One team repaired hearing in guinea pigs using human bone marrow stem cells, while another grew functioning eyes in tadpoles using frog cells.

While there are no immediate uses for humans, they said their findings help describe some of the most basic biological processes underlying the development of hearing and sight, and may help in the development of the new field of regenerative medicine.

“These discoveries illustrate stem cell research’s continuing extraordinary potential to treat a wide range of deadly and disabling diseases that affect millions,” said Anand Swaroop, a stem cell researcher at the National Eye Institute, one of the National Institutes of Health.

Dr. Sujeong Jang of Chonnam National University in Gwang-ju, South Korea, and colleagues used mesenchymal stem cells from human bone marrow to restore hearing in guinea pigs whose hearing had been destroyed using chemicals.

They grew the stem cells into neuron-like cells in lab dishes and then transplanted them into the inner ears of the guinea pigs. Three months later, the animals appeared to have some hearing, Jang told a meeting of the Society for Neuroscience.

Jang said the goal was to regrow the tiny hair cells that are essential for mammals to hear, although she is not sure yet how the stem cells made this happen.

They would eventually like to try something similar in humans, Jang told a news conference.

“When sensitive hair cells in the inner ear of humans and other mammals are killed — by loud noise, autoimmune attack, toxic drugs, or aging — the damage is permanent,” Jang said in a statement.

“Birds and reptiles are luckier. Their damaged hair cells apparently regenerate and can restore normal hearing.”

Michael Zuber and colleagues at the SUNY Upstate Medical University in Syracuse, New York, grew functioning eyes in blinded frog embryos using stem cells.

Usually, frog stem cells just form skin when grown in a dish. Zuber’s team added seven different genetic “factors” that turned on eye formation genes.

When they transplanted the transformed cells into frog embryos, the resulting tadpoles could see out of those eyes, Zuber told the meeting.

They tested the tadpoles by putting white tissue paper over their tank, Zuber said in an interview. Normal tadpoles will stay in the lighter side of the tank, covered by the white paper.

He showed video of blind tadpoles swimming randomly around the tank while the tadpoles with the transplanted cells stayed on the light side.  Continued…


Related Posts:

By Maggie Fox, Health and Science Editor WASHINGTON (Reuters) - Stem cell advocates and researchers are eagerly awaiting the moment next year when president-elect Barack Obama rescinds a directive that limits federal funding of human embryonic stem-cell research. The directive was one of President George W. Bush’s first major acts after taking office in 2001, and Obama

Full Post: Stem cell supporters await their Obama moment

By Ben Hirschler LONDON (Reuters) - Danish drugmaker Novo Nordisk A/S is turning to stem cells in the hunt for a cure for diabetes. The world leader in diabetes care said on Thursday it had launched a new collaboration to develop a treatment for type 1 diabetes by programing stem cells to turn into insulin-producing cells. The alliance

Full Post: Novo taps stem cells in hunt for diabetes cure

LONDON (Reuters) - European regulators on Thursday ruled against allowing a patent on developing human embryonic stem cells, a decision that could stifle research by stem cell companies for commercial purposes. An appeal panel at the European Patent Office upheld a June decision to reject a patent application regarding the use of stem cells filed by

Full Post: European agency rules against stem cell patents

By Julie Steenhuysen CHICAGO (Reuters) - An experimental drug cured guinea pigs infected with a fatal hemorrhagic fever virus, raising hope for its use in a broad range of viral diseases including influenza, hepatitis C, HIV, Ebola and others, U.S. researchers said on Sunday. “This is a whole new strategy for making antiviral drugs,” said Dr. Philip

Full Post: Inside-out cells offer target for antiviral drugs

By Anne Harding NEW YORK (Reuters Health) - Smoke from so-called harm-reduction cigarettes is just as dangerous to developing embryos as smoke from standard cigarettes, and may be even more toxic, new experiments with mouse embryo stem cells show. The smoke issuing from the ends of these cigarettes is more harmful than the fumes inhaled through a

Full Post: “Safer” cigarette smoke just as harmful to embryos

Site Navigation

Most Read